1. Home
  2. ICCC vs CGBS Comparison

ICCC vs CGBS Comparison

Compare ICCC & CGBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • CGBS
  • Stock Information
  • Founded
  • ICCC 1982
  • CGBS 2018
  • Country
  • ICCC United States
  • CGBS Jersey
  • Employees
  • ICCC N/A
  • CGBS N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • CGBS
  • Sector
  • ICCC Health Care
  • CGBS
  • Exchange
  • ICCC Nasdaq
  • CGBS Nasdaq
  • Market Cap
  • ICCC 28.0M
  • CGBS 32.2M
  • IPO Year
  • ICCC 1987
  • CGBS N/A
  • Fundamental
  • Price
  • ICCC $3.66
  • CGBS $0.33
  • Analyst Decision
  • ICCC
  • CGBS
  • Analyst Count
  • ICCC 0
  • CGBS 0
  • Target Price
  • ICCC N/A
  • CGBS N/A
  • AVG Volume (30 Days)
  • ICCC 14.5K
  • CGBS 1.1M
  • Earning Date
  • ICCC 11-13-2024
  • CGBS 01-01-0001
  • Dividend Yield
  • ICCC N/A
  • CGBS N/A
  • EPS Growth
  • ICCC N/A
  • CGBS N/A
  • EPS
  • ICCC N/A
  • CGBS N/A
  • Revenue
  • ICCC $23,838,002.00
  • CGBS N/A
  • Revenue This Year
  • ICCC N/A
  • CGBS N/A
  • Revenue Next Year
  • ICCC N/A
  • CGBS N/A
  • P/E Ratio
  • ICCC N/A
  • CGBS N/A
  • Revenue Growth
  • ICCC 46.37
  • CGBS N/A
  • 52 Week Low
  • ICCC $3.34
  • CGBS $0.26
  • 52 Week High
  • ICCC $5.59
  • CGBS $6.91
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 54.28
  • CGBS N/A
  • Support Level
  • ICCC $3.40
  • CGBS N/A
  • Resistance Level
  • ICCC $3.64
  • CGBS N/A
  • Average True Range (ATR)
  • ICCC 0.16
  • CGBS 0.00
  • MACD
  • ICCC 0.01
  • CGBS 0.00
  • Stochastic Oscillator
  • ICCC 65.12
  • CGBS 0.00

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About CGBS Crown LNG Holdings Limited Ordinary Shares

Crown LNG Holdings Ltd is an LNG infrastructure company that seeks to provide natural gas liquefaction, storage, and re-gasification services. It focuses on enabling a stable and reliable supply of LNG to customers, especially in geographic areas where onshore or floating facilities may be difficult or less desirable as a result of harsh weather conditions, safety or environmental concerns, or cost. It specializes in the design and operation of offshore, all-weather LNG liquefication and re-gasification terminals, such as gravity-based structures. Through Its technologies and design, It believes it can deliver tailored LNG infrastructure suitable for energy-isolated locations, as well as provide critical LNG infrastructure to under-served markets around the world.

Share on Social Networks: